In our cohort, the majority of EBV(+) DLBCL (89%) exhibited expression of LMP-1, with enrichment of latency II and III states, possibly linking the oncogenic activity of LMP-1 with the observed DNA replication signaling pathway in EBV(+) DLBCL. Here, PDLIM7 is linked to diffuse large B-cell lymphoma.